These CAR-NK cells demonstrate strong anti-tumour effects in both spheroid cultures and in vivo models, offering a promising strategy to overcome TGFβ1-mediated immune suppression and improve cancer immunotherapy [195]. This evidence concerns the gene TGFB1 and cancer.